Companies House does not verify the accuracy of the information filed

CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED

Company number 09686738

Follow this company File for this company

Filter by category

Show filing type

Accounts Capital Charges

Confirmation statements / Annual returns Incorporation Officers

Date (document was filed at Companies House)	Type	Description (of the document filed at Companies House)	View / Download (PDF file, link opens in new window)
21 Feb 2024	CS01	Confirmation statement made on 7 February 2024 with no updates	View PDF Confirmation statement made on 7 February 2024 with no updates - link opens in a new window - 3 pages (3 pages)
02 Oct 2023	AA	Accounts for a small company made up to 31 December 2022	View PDF Accounts for a small company made up to 31 December 2022 - link opens in a new window - 17 pages (17 pages)
31 Aug 2023	TM01	Termination of appointment of David John Grainger as a director on 18 August 2023	View PDF Termination of appointment of David John Grainger as a director on 18 August 2023 - link opens in a new window - 1 page (1 page)
22 Aug 2023	TM01	Termination of appointment of David Min Chao as a director on 18 August 2023	View PDF Termination of appointment of David Min Chao as a director on 18 August 2023 - link opens in a new window - 1 page (1 page)
28 Jul 2023	SH19	Statement of capital on 28 July 2023 GBP 1.000001	View PDF Statement of capital on 28 July 2023 GBP 1.000001 - link opens in a new window - 3 pages (3 pages)
28 Jul 2023	SH20	Statement by Directors	View PDF Statement by Directors - link opens in a new window - 2 pages (2 pages)
28 Jul 2023	CAP-SS	Solvency Statement dated 28/07/23	View PDF Solvency Statement dated 28/07/23 - link opens in a new window - 2 pages (2 pages)
28 Jul 2023	RESOLUTIONS	Resolutions RES06 ‐ Resolution of reduction in issued share capital RES13 ‐ Cancel share prem a/c 28/07/2023	View PDF Resolutions RES06 ‐ Resolution of reduction in issued share capital RES13 ‐ Cancel share prem a/c 28/07/2023 - link opens in a new window - 2 pages (2 pages)
03 Apr 2023	CERTNM	Company name changed morphogen-ix LIMITED\certificate issued on 03/04/23 NM04 ‐ Change of name by provision in articles	View PDF Company name changed morphogen-ix LIMITED\certificate issued on 03/04/23 NM04 ‐ Change of name by provision in articles - link opens in a new window - 2 pages (2 pages)
01 Mar 2023	CS01	Confirmation statement made on 7 February 2023 with updates	View PDF Confirmation statement made on 7 February 2023 with updates - link opens in a new window - 4 pages (4 pages)
27 Jan 2023	MA	Memorandum and Articles of Association	View PDF Memorandum and Articles of Association - link opens in a new window - 10 pages (10 pages)
05 Jan 2023	PSC02	Notification of Centessa Pharmaceuticals (Uk) Limited as a person with significant control on 20 December 2022	View PDF Notification of Centessa Pharmaceuticals (Uk) Limited as a person with significant control on 20 December 2022 - link opens in a new window - 2 pages (2 pages)
05 Jan 2023	PSC07	Cessation of Centessa Pharmaceuticals Plc as a person with significant control on 20 December 2022	View PDF Cessation of Centessa Pharmaceuticals Plc as a person with significant control on 20 December 2022 - link opens in a new window - 1 page (1 page)
09 Nov 2022	AP01	Appointment of Richard Menziuso as a director on 1 November 2022	View PDF Appointment of Richard Menziuso as a director on 1 November 2022 - link opens in a new window - 2 pages (2 pages)
06 Oct 2022	AA	Accounts for a small company made up to 31 December 2021	View PDF Accounts for a small company made up to 31 December 2021 - link opens in a new window - 16 pages (16 pages)
01 Aug 2022	TM01	Termination of appointment of Marella Thorell as a director on 31 July 2022	View PDF Termination of appointment of Marella Thorell as a director on 31 July 2022 - link opens in a new window - 1 page (1 page)
25 Jul 2022	CS01	Confirmation statement made on 14 July 2022 with updates	View PDF Confirmation statement made on 14 July 2022 with updates - link opens in a new window - 5 pages (5 pages)
08 Jul 2022	RP04CS01	Second filing of Confirmation Statement dated 14 July 2021	View PDF Second filing of Confirmation Statement dated 14 July 2021 - link opens in a new window - 7 pages (7 pages)
05 Jul 2022	SH08	Change of share class name or designation	View PDF Change of share class name or designation - link opens in a new window - 2 pages (2 pages)
04 Jul 2022	SH10	Particulars of variation of rights attached to shares	View PDF Particulars of variation of rights attached to shares - link opens in a new window - 3 pages (3 pages)
23 Jun 2022	AP01	Appointment of David Min Chao as a director on 17 June 2022	View PDF Appointment of David Min Chao as a director on 17 June 2022 - link opens in a new window - 2 pages (2 pages)
15 Mar 2022	SH01	Statement of capital following an allotment of shares on 14 March 2022 GBP 35,469.22	View PDF Statement of capital following an allotment of shares on 14 March 2022 GBP 35,469.22 - link opens in a new window - 3 pages (3 pages)
10 Jan 2022	PSC05	Change of details for Centessa Pharmaceuticals Limited as a person with significant control on 14 May 2021	View PDF Change of details for Centessa Pharmaceuticals Limited as a person with significant control on 14 May 2021 - link opens in a new window - 2 pages (2 pages)
07 Jan 2022	PSC05	Change of details for Centessa Pharmaceuticals Limited as a person with significant control on 4 May 2021	View PDF Change of details for Centessa Pharmaceuticals Limited as a person with significant control on 4 May 2021 - link opens in a new window - 2 pages (2 pages)
07 Jan 2022	PSC05	Change of details for United Medicines Biopharma Limited as a person with significant control on 17 February 2021	View PDF Change of details for United Medicines Biopharma Limited as a person with significant control on 17 February 2021 - link opens in a new window - 2 pages (2 pages)

Cookies on Companies House services

CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED

Filter by category